Cargando…

Farnesoid X receptor functions in cervical cancer via the p14(ARF)-mouse double minute 2-p53 pathway

BACKGROUND: Cervical cancer is the second most common cancer among women living in developing countries. Farnesoid X receptor (FXR) is a member of the nuclear receptor family, which regulates the development and proliferation of cancer. However, the role of and molecular mechanism by which FXR acts...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Xiaohua, Wang, Bin, Shen, Huimin, Huang, Danmei, Shi, Ganggang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174312/ https://www.ncbi.nlm.nih.gov/pubmed/35347542 http://dx.doi.org/10.1007/s11033-022-07201-x

Ejemplares similares

The Nuclear Farnesoid X Receptor Reduces p53 Ubiquitination and Inhibits Cervical Cancer Cell Proliferation
por: Huang, Xiaohua, et al.
Publicado: (2021)

Pinning Control for the p53-Mdm2 Network Dynamics Regulated by p14ARF
por: Suarez, Oscar J., et al.
Publicado: (2020)

Progressive silencing of p14ARF in oesophageal adenocarcinoma
por: Huang, Yinghui, et al.
Publicado: (2009)

Role of p14ARF-HDM2-p53 axis in SOX6-mediated tumor suppression
por: Wang, J, et al.
Publicado: (2016)

PRL-3 promotes breast cancer progression by downregulating p14(ARF)-mediated p53 expression
por: Xie, Hua, et al.
Publicado: (2018)

P14(ARF): The Absence that Makes the Difference
por: Cilluffo, Danilo, et al.
Publicado: (2020)

Oncomir miR-125b Suppresses p14(ARF) to Modulate p53-Dependent and p53-Independent Apoptosis in Prostate Cancer
por: Amir, Sumaira, et al.
Publicado: (2013)

LRP6 targeting suppresses gastric tumorigenesis via P14(ARF)–Mdm2–P53-dependent cellular senescence
por: Wang, Haibin, et al.
Publicado: (2017)

p14(ARF )expression in invasive breast cancers and ductal carcinoma in situ – relationships to p53 and Hdm2
por: Vestey, SB, et al.
Publicado: (2004)

p14ARF induces the relocation of HDM2 and p53 to extranucleolar sites that are targeted by PML bodies and proteasomes
por: Kashuba, Elena, et al.
Publicado: (2003)

Overexpression of CCDC69 activates p14(ARF)/MDM2/p53 pathway and confers cisplatin sensitivity
por: Cui, Long, et al.
Publicado: (2019)

Oxaliplatin-Induced Senescence in Colorectal Cancer Cells Depends on p14(ARF)-Mediated Sustained p53 Activation
por: Tomicic, Maja T., et al.
Publicado: (2021)

Aberrant Expression of pRb, p16, p14ARF, MDM2, p21 and p53 in Squamous Cell Carcinomas of Lung
por: Xue, Qi, et al.
Publicado: (2001)

Correction: NLRP6 targeting suppresses gastric tumorigenesis via P14(ARF)–Mdm2–P53-dependent cellular senescence
por: Wang, Haibin, et al.
Publicado: (2018)

The Senescence Markers p16INK4A, p14ARF/p19ARF, and p21 in Organ Development and Homeostasis
por: Wagner, Kay-Dietrich, et al.
Publicado: (2022)

Correlation between promoter methylation of p14(ARF), TMS1/ASC, and DAPK, and p53 mutation with prognosis in cholangiocarcinoma
por: Xiaofang, Liu, et al.
Publicado: (2012)

Tissue Specific Induction of p62/Sqstm1 by Farnesoid X Receptor
por: Williams, Jessica A., et al.
Publicado: (2012)

Biological significance of promoter hypermethylation of p14/ARF gene: Relationships to p53 mutational status in Tunisian population with colorectal carcinoma
por: Chaar, Ines, et al.
Publicado: (2013)

Increased Arf/p53 activity in stem cells, aging and cancer
por: Carrasco‐Garcia, Estefania, et al.
Publicado: (2017)

Regulation of p14(ARF )expression by miR-24: a potential mechanism compromising the p53 response during retinoblastoma development
por: To, Kwong-Him, et al.
Publicado: (2012)

Farnesoid X receptor inhibits LNcaP cell proliferation via the upregulation of PTEN
por: LIU, JUN, et al.
Publicado: (2014)

Chimeras of p14ARF and p16: Functional Hybrids with the Ability to Arrest Growth
por: Williams, Richard T., et al.
Publicado: (2014)

The effects of fucodian on senescence are controlled by the p16(INK4a)-pRb and p14(Arf)-p53 pathways in hepatocellular carcinoma and hepatic cell lines
por: MIN, EUN-YOUNG, et al.
Publicado: (2014)

Loss of p53 function at late stages of tumorigenesis confers ARF-dependent vulnerability to p53 reactivation therapy
por: Klimovich, Boris, et al.
Publicado: (2019)

The Farnesoid X Receptor: Good for BAD
por: Keely, Stephen J., et al.
Publicado: (2016)

The Correlation Relationship between P14(ARF) Gene DNA Methylation and Primary Liver Cancer
por: Zhang, Hui, et al.
Publicado: (2015)

Unmasking a new prognostic marker and therapeutic target from the GDNF-RET/PIT1/p14ARF/p53 pathway in acromegaly
por: Chenlo, Miguel, et al.
Publicado: (2019)

Sevoflurane Alleviates Myocardial Ischemia Reperfusion Injury by Inhibiting P2X7-NLRP3 Mediated Pyroptosis
por: Wu, Jiaxuan, et al.
Publicado: (2021)

MDM2-Mediated Degradation of p14ARF: A Novel Mechanism to Control ARF Levels in Cancer Cells
por: Vivo, Maria, et al.
Publicado: (2015)

Corrigendum: Sevoflurane Alleviates Myocardial Ischemia Reperfusion Injury by Inhibiting P2X7-NLRP3 Mediated Pyroptosis
por: Wu, Jiaxuan, et al.
Publicado: (2022)

Farnesoid X Receptor Deficiency Improves Glucose Homeostasis in Mouse Models of Obesity
por: Prawitt, Janne, et al.
Publicado: (2011)

IRES-Mediated Protein Translation Overcomes Suppression by the p14ARF Tumor Suppressor Protein
por: Xi, Song, et al.
Publicado: (2017)

Genetic Variants in the p14ARF/MDM2/TP53 Pathway Are Associated with the Prognosis of Esophageal Squamous Cell Carcinoma Patients Treated with Radical Resection
por: Li, Jing, et al.
Publicado: (2016)

Dynamics of p14ARF and Focal Adhesion Kinase-Mediated Autophagy in Cancer
por: Fontana, Rosa, et al.
Publicado: (2018)

Farnesoid X receptor (FXR): Structures and ligands
por: Jiang, Longying, et al.
Publicado: (2021)

Methylation status of p14ARF and p16INK4a as detected in pancreatic secretions
por: Klump, B, et al.
Publicado: (2003)

Aberrations of the p14(ARF) and p16(INK4a) Genes in Renal Cell Carcinomas
por: Kawada, Yoichi, et al.
Publicado: (2001)

Characterization of ARF-BP1/HUWE1 Interactions with CTCF, MYC, ARF and p53 in MYC-Driven B Cell Neoplasms
por: Qi, Chen-Feng, et al.
Publicado: (2012)

AKT regulates NPM dependent ARF localization and p53(mut) stability in tumors
por: Hamilton, Garth, et al.
Publicado: (2014)

Immortalization of mouse myogenic cells can occur without loss of p16(INK4a), p19(ARF), or p53 and is accelerated by inactivation of Bax
por: Nowak, Jonathan A, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_ce41pui4rcshggb4usmr5pcoen